METTL3 and hepatocellular carcinoma: Xia et al. showed that METTL3-mediated m6A modifications in LCC-CTHCC are recognized by IGF2BP1 and IGF2BP3, crucially stabilizing LCC-CTHCC and increasing its expression in HCC [83].